Evidence map›Paper›PMID 37115584›Full record

ArticleThe Journal of experimental medicine2023

Secretory MPP3 reinforce myeloid differentiation trajectory and amplify myeloid cell production.

Yoon-A Kang, Hyojung Paik, Si Yi Zhang, Jonathan J Chen, Oakley C Olson, Carl A Mitchell, Amelie Collins, James W Swann, Matthew R Warr, Rong Fan and 1 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06924697 (Effect of Glucagon-like Peptide-1), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06924697 naenrolling by invitationstarted 2025, after this paper: background citation

Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients: Study Protocol of a Randomized, Parallel -Controlled Clinical Trial

Ran2025Enrolled46Registered outcomes6Posted comparisons0ConditionsDiabetes Mellitus, Type 2, Nicotine Dependence, CigarettesArmsApplication of GLP-1RAs drugs, DPP-4i group
Open the trial in the graph
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Constraints and tunability of antigen-agnostic memory durability.bioRxiv : the preprint server for biology · 2025
    Article
  10. Differential Response and Recovery Dynamics of HSPC Populations FollowingInternational journal of molecular sciences · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Yoon-A Kang *Columbia Stem Cell Initiative, Department of Genetics and Development, Columbia University , New York, NY, USA.ORCID 0000-0002-0978-5348
Hyojung Paik *Center for Applied Scientific Computing, Korea Institute of Science and Technology Information, and University of Science and Technology , Daejeon, South Korea.ORCID 0000-0002-5803-0670
Si Yi ZhangEli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Department of Medicine, Hem/Onc Division, University of California, San Francisco , San Francisco, CA, USA.ORCID 0000-0002-5793-1151
Jonathan J ChenDepartment of Biomedical Engineering, Yale University , New Haven, CT, USA.ORCID 0000-0002-8231-8420
Oakley C OlsonColumbia Stem Cell Initiative, Department of Genetics and Development, Columbia University , New York, NY, USA.ORCID 0000-0002-0716-5380
Carl A MitchellColumbia Stem Cell Initiative, Department of Genetics and Development, Columbia University , New York, NY, USA.ORCID 0000-0003-2704-9763
Amelie CollinsColumbia Stem Cell Initiative, Department of Genetics and Development, Columbia University , New York, NY, USA.ORCID 0000-0002-0206-1996
James W SwannColumbia Stem Cell Initiative, Department of Genetics and Development, Columbia University , New York, NY, USA.ORCID 0000-0001-7988-9997
Matthew R WarrEli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Department of Medicine, Hem/Onc Division, University of California, San Francisco , San Francisco, CA, USA.ORCID 0000-0003-0710-3785
Rong FanDepartment of Biomedical Engineering, Yale University , New Haven, CT, USA.ORCID 0000-0001-7805-8059
Emmanuelle PasseguéColumbia Stem Cell Initiative, Department of Genetics and Development, Columbia University , New York, NY, USA.ORCID 0000-0002-3516-297X
Columbia University · USUniversity of California, San Francisco · USYale University · USKorea Institute of Science & Technology Information · KR

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Emergency Myelopoiesis Pathways in the Control of Blood ProductionR35HL135763 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PASSEGUE, EMMANUELLE · 2017 to 2023
$5.7M
The Role of JunB in Hematopoietic Stem Cell HomeostasisR01HL092471 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PASSEGUE, EMMANUELLE · 2008 to 2016
$3.6M
Emergency Myelopoiesis in the Pathogenesis of Myeloid MalignanciesR01CA255342 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PASSEGUE, EMMANUELLE · 2021 to 2025
$2.7M
Mapping the unique features of fetal and neonatal hematopoietic stem and progenitor cells conferring susceptibility to inflammation and infectionK08DK124657 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI COLLINS, AMELIE · 2020 to 2023
$663k
Investigating the mechanisms of erythroid lineage commitment in hematopoietic stem and multipotent progenitor populationsK01DK120780 · NIDDK · WASHINGTON UNIVERSITY · PI KANG, YOON A · 2021 to 2023
$508k
Replication Stress and Ribosome Biogenesis in Hematopoietic Stem Cell AgingF31HL160207 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MITCHELL, CARL · 2021 to 2023
$136k
NCI NIH HHS P30 CA013696NCI NIH HHS R01 CA255342NHLBI NIH HHS F31 HL160207NHLBI NIH HHS R01 HL092471NHLBI NIH HHS R35 HL135763NIDDK NIH HHS K01 DK120780NIDDK NIH HHS K08 DK124657
6 · The paper itself

Abstract

Hematopoietic stem cells (HSC) and downstream lineage-biased multipotent progenitors (MPP) tailor blood production and control myelopoiesis on demand. Recent lineage tracing analyses revealed MPPs to be major functional contributors to steady-state hematopoiesis. However, we still lack a precise resolution of myeloid differentiation trajectories and cellular heterogeneity in the MPP compartment. Here, we found that myeloid-biased MPP3 are functionally and molecularly heterogeneous, with a distinct subset of myeloid-primed secretory cells with high endoplasmic reticulum (ER) volume and FcγR expression. We show that FcγR+/ERhigh MPP3 are a transitional population serving as a reservoir for rapid production of granulocyte/macrophage progenitors (GMP), which directly amplify myelopoiesis through inflammation-triggered secretion of cytokines in the local bone marrow (BM) microenvironment. Our results identify a novel regulatory function for a secretory MPP3 subset that controls myeloid differentiation through lineage-priming and cytokine production and acts as a self-reinforcing amplification compartment in inflammatory stress and disease conditions.

Indexed as

HematopoiesisReceptors, IgGCell DifferentiationCell LineageGuanylate KinasesMembrane ProteinsMyeloid CellsGuanylate KinasesMembrane ProteinsReceptors, IgG

Identifiers

PMID37115584
PMCPMC10140385
OpenAlexW4367050150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.